Laurie Alsup

Dr. Laurie S.
Alsup, MD, is an Independent Director at Arvinas, Inc., an Independent Director at Theravance Biopharma, Inc. and a Senior Vice President-Regulatory Science at NDA Group AB. She is on the Board of Directors at Arvinas, Inc., Theravance Biopharma, Inc. and Arvinas Operations, Inc. Dr. Alsup was previously employed as a Lead Independent Director by Pardes Biosciences, Inc., an Independent Director by Kinnate Biopharma, Inc., an Independent Director by BlackBerry Ltd., an Independent Director by KaloBios Pharmaceuticals, Inc., a President & Chief Scientific Officer by PharmApprove LLC, a President & Chief Executive Officer by Phytomedics, Inc., and a VP-Corporate Strategy & Business Risk Management by Bristol Myers Squibb Co. She also served on the board at Kalobios Pharmaceuticals, Inc. She received her undergraduate degree from Fordham University and a doctorate degree from Yale School of Medicine.